For diabetics, access to insulin is a matter of life and death and over the course of 2019, there have been numerous reports that show the increasing price of the medication is keeping it out of reach of patients. And some lawmakers are placing the blame squarely on the shoulders of drugmakers.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,